Tilray Brands, Inc. (NASDAQ:TLRY – Get Free Report) has been assigned an average rating of “Hold” from the eight ratings firms that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, four have assigned a hold rating and three have given a buy rating to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $11.50.
Several analysts have issued reports on TLRY shares. Zacks Research raised shares of Tilray Brands from a “strong sell” rating to a “hold” rating in a research report on Wednesday, February 11th. TD Cowen reduced their target price on shares of Tilray Brands from $10.00 to $7.00 and set a “buy” rating on the stock in a research report on Monday, March 30th. ATB Cormark Capital Markets decreased their target price on shares of Tilray Brands from $9.50 to $9.00 and set a “sector perform” rating for the company in a research note on Thursday, April 2nd. Canaccord Genuity Group assumed coverage on shares of Tilray Brands in a report on Tuesday, January 27th. They set a “hold” rating for the company. Finally, Wall Street Zen raised shares of Tilray Brands from a “sell” rating to a “hold” rating in a research note on Saturday, March 21st.
Check Out Our Latest Report on Tilray Brands
Insider Buying and Selling at Tilray Brands
Institutional Investors Weigh In On Tilray Brands
A number of hedge funds have recently bought and sold shares of TLRY. Hilton Head Capital Partners LLC acquired a new stake in shares of Tilray Brands during the fourth quarter worth $38,000. Pictet Asset Management Holding SA boosted its holdings in shares of Tilray Brands by 38.9% in the 1st quarter. Pictet Asset Management Holding SA now owns 18,387 shares of the company’s stock valued at $119,000 after buying an additional 5,145 shares during the period. Schonfeld Strategic Advisors LLC boosted its holdings in shares of Tilray Brands by 4.5% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 144,358 shares of the company’s stock valued at $1,304,000 after buying an additional 6,182 shares during the period. Baader Bank Aktiengesellschaft grew its position in shares of Tilray Brands by 17.7% during the 1st quarter. Baader Bank Aktiengesellschaft now owns 47,938 shares of the company’s stock valued at $293,000 after buying an additional 7,226 shares during the last quarter. Finally, IFP Advisors Inc grew its position in shares of Tilray Brands by 14.3% during the 4th quarter. IFP Advisors Inc now owns 60,318 shares of the company’s stock valued at $545,000 after buying an additional 7,541 shares during the last quarter. Institutional investors and hedge funds own 9.35% of the company’s stock.
Tilray Brands Price Performance
Shares of NASDAQ TLRY opened at $5.29 on Monday. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.79 and a quick ratio of 1.66. Tilray Brands has a 1-year low of $3.51 and a 1-year high of $23.20. The company has a market capitalization of $616.55 million, a price-to-earnings ratio of -0.39 and a beta of 1.94. The business has a 50-day moving average of $6.34 and a 200-day moving average of $8.12.
Tilray Brands (NASDAQ:TLRY – Get Free Report) last announced its earnings results on Wednesday, April 1st. The company reported ($0.24) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.10). The company had revenue of $206.73 million for the quarter, compared to analysts’ expectations of $201.35 million. Tilray Brands had a negative net margin of 156.51% and a negative return on equity of 3.31%. During the same quarter in the previous year, the business posted ($0.87) earnings per share. On average, equities analysts anticipate that Tilray Brands will post -0.58 EPS for the current fiscal year.
Tilray Brands Company Profile
Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.
Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.
Read More
- Five stocks we like better than Tilray Brands
- The Smart Glasses Gold Rush Is Leaving Old-School Eyewear Behind
- 3 Rare Earth Stocks That Win No Matter What China Does Next
- Amylyx Stock: Why the Full Pipeline Story Matters
- Palantir and Dell Build an AI OS for the Paranoid
Receive News & Ratings for Tilray Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray Brands and related companies with MarketBeat.com's FREE daily email newsletter.
